HER2 positive breast cancer – Life with Disease

Go back

HER2-positive breast cancer is a type of breast cancer that once carried a worrying prognosis, but thanks to major advances in targeted treatments, it has transformed into one of the most treatable forms of the disease.

Understanding the Outlook for HER2-Positive Breast Cancer

When someone receives a diagnosis of HER2-positive breast cancer, it’s natural to wonder what the future holds. This particular type affects around one in five women with breast cancer, meaning approximately 15 to 20 percent of all breast cancer cases test positive for high levels of a protein called human epidermal growth factor receptor 2, or HER2.[1][3]

The good news is that the outlook for people with HER2-positive breast cancer has improved dramatically over the past few decades. Medical experts now describe a remarkable shift in how this disease is viewed. What was once considered one of the most aggressive and difficult-to-treat forms of breast cancer has become highly treatable, especially when caught early. In fact, healthcare providers can successfully cure HER2-positive breast cancer if it’s diagnosed before it spreads to other parts of the body.[2]

The reason for this dramatic change lies in the development of treatments that specifically target the HER2 protein. These therapies work by blocking the signals that tell cancer cells to grow and multiply. When combined with chemotherapy, these targeted treatments cut the risk of the cancer returning in half compared to chemotherapy alone.[11] This means that people with HER2-positive disease actually tend to do better overall than people with some other types of breast cancer, thanks to these highly effective medicines.[1][5]

When discussing survival and prognosis, it’s important to understand that every person’s situation is unique. The outlook depends on several factors, including the stage of cancer when it’s discovered, whether the cancer is also positive for hormone receptors like estrogen or progesterone, and how well the cancer responds to treatment. Early detection makes an enormous difference—when HER2-positive breast cancer is found and treated before it has spread beyond the breast and nearby lymph nodes, the chances of long-term survival are excellent.

⚠️ Important
If you’ve been diagnosed with HER2-positive breast cancer, it’s essential to have your cancer tested at diagnosis and again if it ever comes back or spreads. The HER2 status and hormone receptor status can sometimes change over time, and knowing the current status helps your medical team choose the most effective treatment for your specific situation.[1]

How HER2-Positive Breast Cancer Develops Without Treatment

To understand what happens if HER2-positive breast cancer goes untreated, it helps to know what makes this type of cancer behave the way it does. In healthy breast cells, the HER2 protein sits on the cell surface and helps manage normal cell growth and repair. It ensures that cells divide only when needed to replace damaged or dying cells.[2]

However, when the HER2 gene mutates or malfunctions, it creates too many copies of itself. More HER2 genes lead to more HER2 proteins being produced. When breast cells have excessive amounts of these proteins on their surface, they receive too many growth signals. This causes the cells to grow and divide rapidly in an uncontrolled way, forming tumors.[4]

Without treatment, HER2-positive breast cancer tends to be fast-growing and aggressive compared to some other types of breast cancer. The cancer cells multiply quickly and can form tumors that grow in size. Because of the rapid growth, this type of cancer is more likely to spread, or metastasize, from the breast to other areas of the body.[2][3]

If left unchecked, the cancer can travel through the lymphatic system or bloodstream to distant organs. Common sites where HER2-positive breast cancer may spread include the bones, liver, lungs, and brain. The natural progression without intervention typically involves the tumor growing larger in the breast, potentially spreading to nearby lymph nodes under the arm or near the collarbone, and eventually reaching distant organs if enough time passes without treatment.

Potential Complications to Be Aware Of

Even with treatment, HER2-positive breast cancer can sometimes lead to complications that patients and their families should understand. One of the most significant concerns is the possibility of the cancer spreading beyond the breast. About half of people with this type of breast cancer are diagnosed after the disease has already spread to other areas of their body.[2]

A particularly concerning complication specific to HER2-positive breast cancer is its tendency to spread to the brain. Research shows that up to 50 percent of people with metastatic (stage 4) HER2-positive breast cancer may develop brain metastasis, where cancer cells establish tumors in the brain.[5][20] This can be life-threatening and requires specialized treatment approaches.

Another important complication relates to the heart. Some of the targeted therapies used to treat HER2-positive breast cancer can affect heart function. Certain medications may cause heart problems or weaken the heart muscle over time. This is why doctors carefully monitor heart health before starting treatment and throughout the treatment process. Regular heart checks, often including tests like echocardiograms, help ensure that any heart-related side effects are caught early.[11]

Weight gain is another complication that some people experience during treatment for HER2-positive breast cancer. Studies have found that gaining more than 10 percent of body weight during or after treatment increases the risk of cancer returning and can decrease overall survival time.[23] This weight change can also increase the risk of developing lymphedema, a condition where lymph fluid builds up and causes swelling, particularly if lymph nodes were removed during surgery.[23]

The treatments themselves, while life-saving, can bring their own set of complications. Chemotherapy may cause side effects ranging from nausea and hair loss to “chemo brain,” a term describing problems with memory, concentration, and thinking clearly. Fatigue is common during and after treatment. Some people develop neuropathy, a condition causing numbness, tingling, or pain in the hands and feet.

How HER2-Positive Breast Cancer Affects Daily Life

Living with HER2-positive breast cancer touches nearly every aspect of daily life, from physical capabilities to emotional well-being and social relationships. Understanding these impacts can help patients and their loved ones prepare and find ways to cope.

Physically, the disease and its treatment can be demanding. During active treatment, many people find they have less energy than usual. Simple tasks that once seemed effortless—like climbing stairs, preparing meals, or even taking a shower—can become exhausting. Some people need to take frequent naps or rest periods throughout the day. Work schedules may need to be adjusted, or some individuals may need to take medical leave entirely during intensive treatment phases.

The side effects of treatment can interfere with everyday activities. Hair loss, while temporary, can be emotionally difficult and may affect how comfortable someone feels in social situations. Changes in appetite or taste can make eating less enjoyable and may require adjustments to diet and meal planning. Some treatments cause digestive issues that require staying close to bathroom facilities, which can limit the ability to travel or participate in activities.

Exercise and physical activity, while beneficial, may need to be modified. However, staying active during treatment is actually encouraged, as women who remain physically active during chemotherapy often seem to handle treatment better.[18] This might mean switching from high-impact activities to gentler options like walking, yoga, or swimming. The key is finding a level of activity that feels manageable without being overwhelming.

Emotionally, a breast cancer diagnosis can trigger a wide range of feelings. Anxiety about the future is common, as is fear about treatment, possible recurrence, or leaving loved ones behind. Some people experience depression, especially during the difficult phases of treatment. Anger, sadness, and grief for the life that existed before cancer are all normal responses. The mental health impact can be just as significant as the physical challenges, and many people benefit from seeing a mental health professional who specializes in cancer care.[18]

Relationships and social life often shift in complex ways. Some people find that their diagnosis brings them closer to family and friends, while others may feel isolated or misunderstood. Intimate relationships can be affected by physical changes, fatigue, and emotional stress. Some people struggle with changes to their body image, especially after surgery or during hair loss. Open communication with partners, family members, and close friends becomes crucial during this time.

Work life typically requires adjustments. Some people can continue working throughout treatment with modifications like reduced hours or the ability to work from home. Others need to take extended leave. Financial concerns often arise, as medical bills accumulate and income may be reduced. Many patients find it helpful to talk with a social worker or financial counselor about available resources and assistance programs.

Finding ways to maintain a sense of normalcy and control can help tremendously. This might include keeping up with hobbies that bring joy, setting boundaries about when and how to discuss cancer with others, and allowing yourself to say no to obligations that feel too demanding. Small acts of self-care—like reading a favorite book, taking a warm bath, or simply sitting quietly with a cup of tea—can provide moments of peace in an otherwise chaotic time.[18]

⚠️ Important
Many people find that connecting with others who understand what they’re going through makes a significant difference. Support groups, whether in person or online, can provide a safe space to share experiences, ask questions, and learn from others who have walked the same path. Don’t hesitate to ask family and friends for specific help when you need it—whether that’s a ride to treatment, help with household tasks, or simply someone to sit with you.[18]

Supporting Family Members Through Clinical Trials

If you’re a family member of someone with HER2-positive breast cancer, you may hear about clinical trials as a treatment option. Understanding what clinical trials are and how to support your loved one through the decision-making process can be incredibly valuable.

Clinical trials are research studies that test new treatments, procedures, or ways of using existing treatments for cancer. For HER2-positive breast cancer, clinical trials might involve testing new targeted therapies, combinations of existing drugs, or innovative approaches to preventing the cancer from returning. These studies are essential for advancing cancer care and have been responsible for the dramatic improvements in HER2-positive breast cancer treatment over the past decades.[7]

Your loved one’s doctor may mention clinical trials as an option, particularly if standard treatments haven’t worked as hoped or if they qualify for a study testing promising new approaches. It’s important to understand that participating in a clinical trial is always voluntary, and patients can withdraw at any time if they choose to do so.

As a family member, you can help by encouraging open conversations with the medical team about whether a clinical trial might be appropriate. Help gather information about any trials being considered. This includes understanding what the trial is testing, what phase of research it represents, what the potential benefits and risks are, and what the time commitment involves. Many trials require frequent visits to the treatment center, which may mean additional travel and logistical planning.

Supporting someone through clinical trial participation might mean helping keep track of appointments, side effects, and medication schedules. It could involve going along to appointments to help listen and ask questions—having an extra set of ears can be helpful when processing complex medical information. You might help with practical matters like transportation, childcare, or meal preparation to make it easier for your loved one to focus on treatment.

It’s also important to support the emotional side of clinical trial participation. Your loved one may feel hopeful about accessing cutting-edge treatment, but they might also feel anxious about unknowns or guilt if they’re in the group receiving the standard treatment rather than the experimental one in a randomized trial. Listening without judgment and validating their feelings can provide tremendous comfort.

Help advocate for your loved one if needed. If they’re having trouble getting clear answers from the research team or if concerns aren’t being addressed, you can help them speak up or speak on their behalf if they’re too tired or unwell to do so themselves. Make sure they understand that they have rights as a research participant, including the right to ask questions, to understand what’s happening, and to stop participating if they choose.

Finally, help your loved one think through practical considerations. Will insurance cover costs not related to the research? Are there additional out-of-pocket expenses? How will participation affect work schedules or family routines? Working through these details together can reduce stress and help everyone feel more prepared for what lies ahead.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Trastuzumab (Herceptin) – An antibody drug that attaches to HER2 proteins on cancer cells to slow or stop their growth, used for both early and metastatic HER2-positive breast cancer

Ongoing Clinical Trials on HER2 positive breast cancer

  • Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

    Recruiting

    4 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Hungary +5
  • Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Spain
  • Study evaluating HER2DX-guided treatment in patients with early-stage HER2-positive breast cancer using trastuzumab, pertuzumab and combination chemotherapy

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Ireland Spain
  • Study of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

    Recruiting

    2 1 1 1
    Belgium The Netherlands
  • Study on the Safety and Effects of Lutetium Lu-177 and ABY-271 in Patients with HER2-Positive Metastatic Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Sweden
  • A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

    Recruiting

    3 1 1 1
    Investigated drugs:
    Germany
  • Study on Trastuzumab, Pertuzumab, and Tucatinib for Patients with Stage II-III HER2-Positive Breast Cancer Without Chemotherapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

    Recruiting

    3 1
    Investigated drugs:
    Austria Belgium France Germany Ireland Italy +4
  • Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium France Italy Spain
  • Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment

    Recruiting

    2 1 1 1
    Belgium France Poland Portugal Spain

References

https://www.mayoclinic.org/diseases-conditions/breast-cancer/expert-answers/breast-cancer/faq-20058066

https://my.clevelandclinic.org/health/diseases/25213-her2-positive-breast-cancer

https://nbcf.org.au/about-breast-cancer/diagnosis/her2-positive-breast-cancer/

https://www.bcrf.org/about-breast-cancer/her2-status-breast-cancer/

https://www.komen.org/blog/know-more-her2-positive-breast-cancer/

https://www.mdanderson.org/cancerwise/her2-positive-breast-cancer–what-it-is–diagnosis-and-treatment.h00-159542112.html

https://www.bcrf.org/about-breast-cancer/her2-positive-breast-cancer-treatment-research/

https://pubmed.ncbi.nlm.nih.gov/24508693/

https://www.mdanderson.org/cancerwise/her2-positive-breast-cancer–what-it-is–diagnosis-and-treatment.h00-159542112.html

https://www.bcrf.org/about-breast-cancer/her2-positive-breast-cancer-treatment-research/

https://www.komen.org/breast-cancer/treatment/type/her2-targeted-therapies/trastuzumab/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6122384/

https://my.clevelandclinic.org/health/diseases/25213-her2-positive-breast-cancer

https://www.aacr.org/patients-caregivers/progress-against-cancer/a-new-treatment-option-for-her2-positive-breast-cancer/

https://www.breastcancer.org/treatment/targeted-therapy/what-are-anti-her2-therapies

https://my.clevelandclinic.org/health/diseases/25213-her2-positive-breast-cancer

https://www.bcrf.org/about-breast-cancer/her2-positive-breast-cancer-treatment-research/

https://www.webmd.com/breast-cancer/lst/listicle-her2-positive-self-care

https://tolife.org/about-us-1/blog/her2-positive-breast-cancer-diet

https://www.komen.org/blog/know-more-her2-positive-breast-cancer/

https://www.youtube.com/watch?v=boIO9i2HvuM

https://www.healthline.com/health/her2-positive-foods-to-avoid

https://www.mybcteam.com/resources/her2-positive-breast-cancer-survivorship-moving-forward-and-staying-healthy

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What does it mean when breast cancer is HER2-positive?

HER2-positive breast cancer means that tests show high levels of a protein called HER2 (human epidermal growth factor receptor 2) on the surface of cancer cells. About 15 to 20 percent of breast cancers are HER2-positive. This protein normally helps manage cell growth, but when there’s too much of it, cancer cells grow and divide faster. The good news is that there are highly effective targeted treatments specifically designed to block this protein and slow or stop cancer growth.

Is HER2-positive breast cancer more dangerous than other types?

HER2-positive breast cancer used to be considered more aggressive and difficult to treat. However, thanks to major advances in targeted therapies over the past few decades, people with HER2-positive disease now actually tend to do better than people with some other types of breast cancer. When caught early and treated with appropriate HER2-targeted therapies combined with chemotherapy, the outlook is quite good.

Can the HER2 status of my cancer change over time?

Yes, the HER2 status can change if the cancer comes back or spreads. This is why medical experts recommend retesting the cancer if it recurs or metastasizes. The hormone receptor status can also change. Knowing the current status of your cancer helps your healthcare team choose the most effective treatment for your specific situation at that time.

What are the chances of HER2-positive breast cancer spreading to the brain?

Research shows that up to 50 percent of people with metastatic (stage 4) HER2-positive breast cancer may develop brain metastasis, where cancer spreads to the brain. This is a higher rate than some other types of breast cancer. However, newer treatments are being developed that can better cross into the brain to target cancer cells there, and doctors monitor closely for any signs of brain involvement so they can act quickly if needed.

Will I need to take medicine for the rest of my life if I have HER2-positive breast cancer?

It depends on the stage of your cancer. For early-stage HER2-positive breast cancer, targeted therapy like trastuzumab is typically given for one year after surgery. If the cancer is metastatic (stage 4), treatment is usually ongoing for as long as it’s working to control the cancer and maintain quality of life. Your specific treatment plan will be tailored to your individual situation and may change over time based on how you respond.

🎯 Key takeaways

  • HER2-positive breast cancer, once one of the most feared diagnoses, has become highly treatable thanks to targeted therapies that specifically block the HER2 protein driving cancer growth
  • About one in five breast cancers (15-20 percent) test positive for excess HER2 protein, and all newly diagnosed breast cancers should be tested for HER2 status
  • When treated with HER2-targeted therapy plus chemotherapy, the risk of cancer returning is cut in half compared to chemotherapy alone—a remarkable improvement in outcomes
  • Early detection makes an enormous difference, as HER2-positive breast cancer can often be cured when found before it spreads beyond the breast and nearby lymph nodes
  • Brain metastasis is a particular concern with HER2-positive breast cancer, affecting up to half of people with metastatic disease, which is why close monitoring is essential
  • Living with HER2-positive breast cancer affects physical energy, emotional well-being, relationships, and work life—making self-care and support systems crucial throughout treatment
  • Maintaining a healthy weight and eating a diet rich in vegetables and fiber while limiting saturated fats can improve survival rates and overall health during and after treatment
  • Clinical trials have been responsible for the dramatic improvements in HER2-positive breast cancer treatment and continue to offer access to promising new therapies